Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention-Reference-Cited by-同舟云学术

Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention

Published:2016-03 Issue:5 Volume:146 Page:199-202
ISSN:0025-7753
Container-title:Medicina Clínica
language:en
Short-container-title:Medicina Clínica

Author:

Vila-Corcoles Angel,Ansa Xabier,Ochoa-Gondar Olga,Satue Eva,de Diego Cinta,Rodriguez-Blanco Teresa

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known;Fedson;Vaccine,1999

2. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines;Lynch;Curr Opin Pulm Med,2010

3. Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke;Vila-Corcoles;BMC Public Health,2010

4. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥60 years: 3 years of follow-up in the CAPAMIS study;Ochoa-Gondar;Clin Infect Dis,2014

5. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain;Gutierrez;Clin Infect Dis,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nursing Care Process for patients with Pneumonia and Arterial Hypertension in the Emergency Department of a hospital in Lima;AG Salud;2023-12-19

2. Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis;eClinicalMedicine;2022-02

3. Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2021-06-09

4. Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence;Expert Review of Vaccines;2021-02-20

5. Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage;Antimicrobial Agents and Chemotherapy;2020-01-27